(0.10%) 5 052.50 points
(0.09%) 38 502 points
(0.14%) 17 374 points
(-1.12%) $81.92
(0.61%) $1.802
(-1.45%) $2 312.40
(-1.49%) $26.84
(-1.00%) $922.00
(-0.03%) $0.938
(0.19%) $11.01
(-0.08%) $0.809
(-0.10%) $93.32
Live Chart Being Loaded With Signals
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan...
Stats | |
---|---|
Today's Volume | 28 800.00 |
Average Volume | 69 436.00 |
Market Cap | 63.43B |
EPS | ¥0 ( 2024-02-04 ) |
Next earnings date | ( ¥0 ) 2024-05-10 |
Last Dividend | ¥8.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 9.74 |
ATR14 | ¥1.509 (0.07%) |
Volume Correlation
ASKA Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ASKA Pharmaceutical Correlation - Currency/Commodity
ASKA Pharmaceutical Financials
Annual | 2022 |
Revenue: | ¥60.46B |
Gross Profit: | ¥28.59B (47.28 %) |
EPS: | ¥150.08 |
Q3 | 2023 |
Revenue: | ¥17.18B |
Gross Profit: | ¥8.44B (49.16 %) |
EPS: | ¥82.21 |
Q2 | 2023 |
Revenue: | ¥15.63B |
Gross Profit: | ¥7.72B (49.43 %) |
EPS: | ¥95.41 |
Q1 | 2023 |
Revenue: | ¥16.02B |
Gross Profit: | ¥7.46B (46.58 %) |
EPS: | ¥50.48 |
Financial Reports:
No articles found.
ASKA Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥8.00 (N/A) |
¥0 (N/A) |
¥8.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥7.00 | 2021-09-29 |
Last Dividend | ¥8.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | ¥31.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.90 | |
Div. Directional Score | 7.56 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8203.T | Ex Dividend Junior | 2024-02-28 | Annually | 0 | 0.00% | |
7593.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6787.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
6134.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4832.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
4044.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3271.T | Ex Dividend Junior | 2024-06-27 | Sporadic | 0 | 0.00% | |
2294.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
9143.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7995.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.105 | 1.500 | 7.90 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0687 | 1.200 | 7.71 | 9.25 | [0 - 0.3] |
returnOnEquityTTM | 0.113 | 1.500 | 9.85 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.88 | 0.800 | 0.604 | 0.483 | [1 - 3] |
quickRatioTTM | 1.797 | 0.800 | 4.14 | 3.31 | [0.8 - 2.5] |
cashRatioTTM | 0.811 | 1.500 | 6.61 | 9.91 | [0.2 - 2] |
debtRatioTTM | 0.107 | -1.500 | 8.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 130.07 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 204.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 204.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.167 | -1.500 | 9.33 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.481 | 1.000 | 5.31 | 5.31 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0902 | 1.000 | -0.197 | -0.197 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.574 | 1.000 | 7.92 | 7.92 | [0.2 - 2] |
assetTurnoverTTM | 0.654 | 0.800 | 8.97 | 7.18 | [0.5 - 2] |
Total Score | 11.22 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.49 | 1.000 | 9.14 | 0 | [1 - 100] |
returnOnEquityTTM | 0.113 | 2.50 | 9.91 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 204.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.834 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 204.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -12.58 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0935 | 1.000 | -0.161 | 0 | [0.1 - 0.5] |
Total Score | 3.90 |
ASKA Pharmaceutical
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators